急性胰腺炎质量指标制定:急性胰腺炎质量工作组
急性胰腺炎质量工作组采用改良RAND/UCLA适宜性方法,召集多学科专家小组,经文献回顾与三轮评审制定质量指标。最终从71项候选指标中确定40项既有效又必要的质量指标及绩效阈值,覆盖诊断、病因、初始评估与风险分层等10个领域。
要点
- 多学科专家经三轮评审从71项候选指标中确定40项有效且必要的质量指标。
- 质量指标覆盖诊断、病因、初始评估与风险分层等10个急性胰腺炎管理领域。
- 40项质量指标附绩效阈值,为监测急性胰腺炎诊疗质量提供定量框架。
核心结论
- 该医师主导的倡议正式制定了40项急性胰腺炎管理质量指标及绩效阈值目标。
- 经验证的质量指标为卫生系统监测已知或疑似急性胰腺炎患者诊疗质量提供可靠的定量框架。
研究设计与样本
- 急性胰腺炎质量工作组采用改良版RAND/UCLA适宜性方法制定质量指标。
- 召集由胃肠病学家、医院医师和外科医生组成的多学科专家小组,代表地理和实践环境多样性。
- 进行文献回顾并制定候选质量指标清单,专家小组经三轮评审:第一轮独立评分(95%参与),第二轮面对面讨论(75%参与),第三轮评定必要性和绩效阈值(90%参与)。
主要发现
- 第一轮评审中,71项候选质量指标(覆盖10个急性胰腺炎领域)连同支持文献发送给专家小组独立评分。
- 第二轮面对面讨论后,41项质量指标被分类为有效。
- 第三轮中,专家小组对41项有效质量指标评定必要性和提出绩效阈值,最终确定40项既有效又必要。
关键数值与推荐
- 最终确定40项既有效又必要的质量指标,覆盖诊断、病因、初始评估与风险分层等10个急性胰腺炎领域。
- 41项质量指标在第二轮被分类为有效,其中40项在第三轮被评定为既有效又必要。
- 质量指标基于科学证据、偏倚、可解释性、有效性、必要性和提议的绩效目标进行评分。
临床怎么用
- 管理已知或疑似急性胰腺炎患者的医院和提供者应确保患者根据当前循证最佳实践获得高质量护理和期望结局。
- 经验证的质量指标为卫生系统监测已知或疑似急性胰腺炎患者诊疗质量提供定量框架。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Detailed recommendations and guidelines for acute pancreatitis (AP) management currently exist. However, quality indicators (QIs) are required to measure performance in health care. The goal of the Acute Pancreatitis Task Force on Quality was to formally develop QIs for the management of patients with known or suspected AP using a modified version of the RAND/UCLA Appropriateness Methodology. METHODS: A multidisciplinary expert panel composed of physicians (gastroenterologists, hospitalists, and surgeons) who are acknowledged leaders in their specialties and who represent geographic and practice setting diversity was convened. A literature review was conducted, and a list of proposed QIs was developed. In 3 rounds, panelists reviewed literature, modified QIs, and rated them on the basis of scientific evidence, bias, interpretability, validity, necessity, and proposed performance targets. RESULTS: Supporting literature and a list of 71 proposed QIs across 10 AP domains (Diagnosis, Etiology, Initial Assessment and Risk Stratification, etc.) were sent to the expert panel to review and independently rate in round 1 (95% of panelists participated). Based on a round 2 face-to-face discussion of QIs (75% participation), 41 QIs were classified as valid. During round 3 (90% participation), panelists rated the 41 valid QIs for necessity and proposed performance thresholds. The final classification determined that 40 QIs were both valid and necessary. DISCUSSION: Hospitals and providers managing patients with known or suspected AP should ensure that patients receive high-quality care and desired outcomes according to current evidence-based best practices. This physician-led initiative formally developed 40 QIs and performance threshold targets for AP management. Validated QIs provide a dependable quantitative framework for health systems to monitor the quality of care provided to patients with known or suspected AP.
引用
- Vivian E, Cler L, Conwell D, et al. Acute Pancreatitis Task Force on Quality: Development of Quality Indicators for Acute Pancreatitis Management. Am J Gastroenterol. 2019. PMID: 31205135. doi:10.14309/ajg.0000000000000264
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。